Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -11.80.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-459.91
EARNINGS PER SHARE (EPS) AVG 3Y
-720819.96
EARNINGS PER SHARE (EPS) AVG 5Y
-483554.38
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Akanda Corp.
Market Cap
$61580.00
Earnings Per Share (EPS)
N/A
TTM Avg
-459.91
3Y Avg
-720819.96
5Y Avg
-483554.38
Market Cap
$30509.00
Earnings Per Share (EPS)
N/A
TTM Avg
-110.58
3Y Avg
-60.80
5Y Avg
-49.51
Market Cap
$6500.00
Earnings Per Share (EPS)
N/A
TTM Avg
-24.78
3Y Avg
156.25
5Y Avg
124.99
Market Cap
$379496.00
Earnings Per Share (EPS)
N/A
TTM Avg
-48.50
3Y Avg
-108.50
5Y Avg
-157.67
Market Cap
$559702.00
Earnings Per Share (EPS)
-54.17
TTM Avg
-34.20
3Y Avg
-18.78
5Y Avg
-13.04
Market Cap
$669300.00
Earnings Per Share (EPS)
-5669.00
TTM Avg
-313854.00
3Y Avg
-213259.50
5Y Avg
-170757.60
Market Cap
$820528.00
Earnings Per Share (EPS)
-11.80
TTM Avg
-236.00
3Y Avg
-263.84
5Y Avg
-205.13
Market Cap
$835190.00
Earnings Per Share (EPS)
-29.09
TTM Avg
-56.46
3Y Avg
-589.82
5Y Avg
-783.52
Market Cap
$861994.00
Earnings Per Share (EPS)
-180.45
TTM Avg
-617.40
3Y Avg
-559.80
5Y Avg
-483.70
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akanda Corp. (AKAN) | $61580.00 | N/A | -459.91 | -720819.96 | -483554.38 |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | N/A | -110.58 | -60.80 | -49.51 |
| NewGenIvf Group Limited (NIVF)vs › | $6500.00 | N/A | -24.78 | 156.25 | 124.99 |
| Niki BioSolutions, Inc. (NIKI)vs › | $379496.00 | N/A | -48.50 | -108.50 | -157.67 |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | -54.17 | -34.20 | -18.78 | -13.04 |
| CDT Equity Inc. (CDT)vs › | $669300.00 | -5669.00 | -313854.00 | -213259.50 | -170757.60 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $820528.00 | -11.80 | -236.00 | -263.84 | -205.13 |
| Decoy Therapeutics Inc. (DCOY)vs › | $835190.00 | -29.09 | -56.46 | -589.82 | -783.52 |
| GlucoTrack, Inc. (GCTK)vs › | $861994.00 | -180.45 | -617.40 | -559.80 | -483.70 |
| Bone Biologics Corporation (BBLG)vs › | $870069.00 | -1.86 | -3.74 | -18.16 | -24.28 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -662.22 |
| 2024-12-31 | -257.60 |
| 2023-12-31 | -2865532.00 |
| 2022-12-31 | -16828.00 |
| 2021-12-31 | -14066.48 |
| 2020-12-31 | -3980.00 |
| 2019-12-31 | -2412.48 |
